1. Home
  2. MMT vs NKTR Comparison

MMT vs NKTR Comparison

Compare MMT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMT
  • NKTR
  • Stock Information
  • Founded
  • MMT 1987
  • NKTR 1990
  • Country
  • MMT United States
  • NKTR United States
  • Employees
  • MMT N/A
  • NKTR N/A
  • Industry
  • MMT Trusts Except Educational Religious and Charitable
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MMT Finance
  • NKTR Health Care
  • Exchange
  • MMT Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • MMT 270.5M
  • NKTR 247.9M
  • IPO Year
  • MMT N/A
  • NKTR 1994
  • Fundamental
  • Price
  • MMT $4.74
  • NKTR $1.07
  • Analyst Decision
  • MMT
  • NKTR Buy
  • Analyst Count
  • MMT 0
  • NKTR 3
  • Target Price
  • MMT N/A
  • NKTR $4.00
  • AVG Volume (30 Days)
  • MMT 86.5K
  • NKTR 1.9M
  • Earning Date
  • MMT 01-01-0001
  • NKTR 11-07-2024
  • Dividend Yield
  • MMT 8.58%
  • NKTR N/A
  • EPS Growth
  • MMT N/A
  • NKTR N/A
  • EPS
  • MMT 0.30
  • NKTR N/A
  • Revenue
  • MMT N/A
  • NKTR $93,137,000.00
  • Revenue This Year
  • MMT N/A
  • NKTR $12.85
  • Revenue Next Year
  • MMT N/A
  • NKTR N/A
  • P/E Ratio
  • MMT $15.33
  • NKTR N/A
  • Revenue Growth
  • MMT N/A
  • NKTR 5.53
  • 52 Week Low
  • MMT $4.04
  • NKTR $0.46
  • 52 Week High
  • MMT $4.70
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • MMT 53.80
  • NKTR 40.85
  • Support Level
  • MMT $4.65
  • NKTR $0.98
  • Resistance Level
  • MMT $4.71
  • NKTR $1.21
  • Average True Range (ATR)
  • MMT 0.04
  • NKTR 0.08
  • MACD
  • MMT 0.01
  • NKTR 0.00
  • Stochastic Oscillator
  • MMT 88.24
  • NKTR 23.08

About MMT MFS Multimarket Income Trust

MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: